Skip to main content

Appili Therapeutics

Halifax, Canada

Appili Therapeutics is an anti-infective pharmaceutical development company.

$532K raised
Nov 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Appili Therapeutics

How much funding has Appili Therapeutics raised?
Appili Therapeutics has raised $532K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Who are Appili Therapeutics's investors?
Appili Therapeutics's investors include U.S. Department of War, The Lind Partners, Atlantic Canada Opportunities Agency, National Research Council of Canada Industrial Research Assistance Program, Innovacorp.
Where is Appili Therapeutics headquartered?
Appili Therapeutics is headquartered in Halifax, Canada.
What does Appili Therapeutics do?
Appili Therapeutics is an anti-infective pharmaceutical development company.
What stage is Appili Therapeutics at?
Appili Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Appili Therapeutics — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/appili-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Appili Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/appili-therapeutics
Wikipedia (cite web)
{{cite web |title=Appili Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/appili-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .